Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study.
Banerji U. et al, (2019), Lancet Oncol, 20, 1124 - 1135
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine-resistance in breast cancer
Morotti M. et al, (2019), Proceedings of the National Academy of Sciences of the United States of America
Integrated pharmacodynamic analysis identifies two metabolic adaption pathways to metformin in breast cancer
Lord SR. et al, (2018), Cell Metabolism
Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients.
Morotti M. et al, (2018), Eur J Drug Metab Pharmacokinet, 43, 137 - 153
Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer
Teoh EJ. et al, (2017), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 44, S633 - S634
A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO).
Hall PS. et al, (2017), British journal of cancer, 116, 472 - 478
Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment.
Mehta S. et al, (2016), EBioMedicine, 10, 109 - 116
Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality.
Lord S. et al, (2016), Curr Drug Targets, 17, 1714 - 1727
Window of opportunity studies: investigating the bioactivity of metformin in cancer
Lipplaa A. et al, (2015), Journal of Endocrinology, Diabetes and Obesity
Can D-Dimer Measurement Reduce the Frequency of Radiological Assessment in Patients Receiving Palliative Imatinib for Gastrointestinal Stromal Tumor (GIST)?
Afshar M. et al, (2015), Cancer Investigation, 33, 347 - 353
Early phase cancer clinical trials: design, ethics and future directions.
Coupe N. et al, (2015), Br J Hosp Med (Lond), 76, 409 - 413
Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer Metabolism.
Lord SR. et al, (2015), J Natl Cancer Inst Monogr, 2015, 81 - 86
Imaging tumour hypoxia with positron emission tomography.
Fleming IN. et al, (2015), Br J Cancer, 112, 238 - 250
Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation.
Bensaad K. et al, (2014), Cell Rep, 9, 349 - 365
METFORMIN'S EFFECTS ON BREAST CANCER LIPID METABOLISM
Lord SR. et al, (2011), ANNALS OF ONCOLOGY, 22, 31 - 31
METFORMIN'S EFFECTS ON BREAST CANCER LIPID METABOLISM
Lord SR. et al, (2011), ANNALS OF ONCOLOGY, 22